Milking nature for Alzheimer's treatment

Drug Discovery Today

Volumn 6, Issue 17, 2001, Pages 866-868

  Owens, Joanna ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; COLOSTRININ; MILK PROTEIN; NEW DRUG; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; COLOSTRUM; DRUG MECHANISM; DRUG RESEARCH; HUMAN; LEARNING; MEMORY; NERVE DEGENERATION; NONHUMAN; RAT; SHORT SURVEY;

EID: 0035450982     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01949-3     Document Type: Short Survey

References (10)

1. Protein and the neurofibrillary pathology of Alzheimer's disease
2. Activated microglia and cerebral amyloid deposits in Alzheimer's disease
3. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid peptide
4. The presence of glycated tau in Alzheimer's disease: a mechanism for induction of oxidant stress
5. Colostrinin, a polypeptide isolated from early milk, facilitates learning and memory in rats
6. Cognitive effects of Colostral-Val nonapeptide in aged rats
7. Colostrinin™: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study
8. Transcriptional inhibition of the α-amyloid precursor protein by interferon γ
9. Tumor necrosis factors α and β protect neurons against amyloid β peptide toxicity
10. Colostrinin™: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes